Vestagen is an Orlando-based developer of advanced performance textile products and technologies centered on its VESTEX® Active Barrier line. VESTEX combines antimicrobial, liquid-repellent and breathable properties to reduce risks from unanticipated fluid exposures during routine use as general-purpose healthcare attire. The company produces scrubs, lab coats and patient garments built on this technology. VESTEX uniforms are being adopted by healthcare institutions including Northwell Health and Baptist Health System. Vestagen plans to use recent financing proceeds for general corporate purposes and to increase commercialization activities for its VESTEX products. Bill Bold serves as Chief Executive Officer. Vestagen Technical Textiles develops and markets performance apparel products and technologies, centered on its VESTEX® active barrier protective technology. VESTEX® combines fluid repellent, antimicrobial and breathability properties for everyday protection from fluid exposure and pathogen transmission. The technology is suitable for healthcare, public safety, athletics and other demanding applications and is available for use in garment production by approved licensees. The company completed a $7.0m financing extension to support commercialization of VESTEX®. Vestagen is based in Orlando, Florida and is led by newly named CEO Bill Bold, who replaced Dale Pfost, PhD. The financing and management change signal a push toward commercial rollout of its protective apparel offerings. Vestagen Technical Textiles, based in Orlando, FL, develops and markets advanced performance textile products and technologies. Its core product is Vestex, a class of active barrier protective fabrics that combine antimicrobial, liquid-repellent and breathability properties. The company designs uniforms and scrubs from Vestex to protect healthcare workers and patients from dangerous contaminants. Vestagen completed an $8.25M financing led by Advent Life Sciences, with participation from Alliance Healthcare Investment Fund, founding investor V-Ten Capital and other private investors. In conjunction with the financing, Dale Pfost of Advent joined Vestagen’s Board as executive chairman and Joe Mayernik of Alliance Healthcare Investment Fund joined as a director. The company intends to use the funds to accelerate the commercial launch of medical scrub uniforms and other protective apparel made from its proprietary Vestex fabrics.

Total raised

$25M

Funding rounds

3

Latest round

Equity

Latest activity

Apr 2017